ResMed’s myAir improves CPAP adherence

LYON, France – CPAP users who track their treatment with ResMed’s myAir mobile app use their devices, on average, 46 minutes longer per night than patients who do not use the app, according to a paper recently published by Price Waterhouse Cooper. “These latest findings confirm that enabling patients to track and improve their CPAP device usage is an important step toward long-term compliance and better patient outcomes,” said David Jones, sleep manager at University Hospital of South Manchester, United Kingdom. About 23,000 patients in Germany, the U.K. and Ireland participated in the study, 1,800 of which have registered for myAir. The study also found that myAir users have higher adherence rates than other patients, about 81% to 68% in the eighth week of treatment.